EDTUTC-4 New YorkLog in Sign up

SUPN
Supernus Pharmaceuticals, Inc.
stockNASDAQ

Market OpenOct 29, 2026 9:41:53 AM EDT

43.27USD+5.331%(+2.19)56,110

Pre-marketOct 29, 2026 9:27:30 AM EDT

43.40USD+5.648%(+2.32)

43.05Bid43.52Ask0.47Spread

SUPN News

Day breaks

05:43 PM EDTUpdated Effective Date: Huron Consulting Group Set to Join S&P SmallCap 600 ·

PR Newswire

08:30 AM EDTChloe Kim Is Changing the Conversation Around ADHD in Women with Qelbree® for ‘Ms. Represented’ Campaign ·

GlobeNewswire Inc.

08:47 AM EDTOppenheimer's top 50 small- and mid-cap Sell ideas ·

Seeking Alpha

04:52 PM EDTSupernus Pharmaceuticals ends UBS credit line ahead of Indivior merger ·

Investing.com

01:19 AM EDTMSG Rangers and Huron Consulting Group to join S&P SmallCap 600 ·

Seeking Alpha

07:45 PM EDTSupernus Announces Orphan Drug Exclusivity for ONAPGO™ (apomorphine HCl) ·

GlobeNewswire Inc.

08:30 AM EDTSupernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026 ·

GlobeNewswire Inc.

03:42 PM EDTSupernus Pharmaceuticals stock hits 52-week low at 40.5 USD ·

Investing.com

04:56 PM EDTNewron Provides Update on FDA Clinical Hold and Phase 3 ENIGMA-TRS Development Program ·

NewMediaWire

07:38 AM EDTAre ITGR, BZH, SUPN Obtaining Fair Deals for their Shareholders? ·

PR Newswire

05:40 PM EDTSupernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN ·

Business Wire

05:16 PM EDTSupernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN ·

Business Wire

10:10 AM EDT10 mid-cap U.S. healthcare stocks with the weakest momentum grades ·

Seeking Alpha